You are here: Home - Investing - Experienced Investor - News -

Stock of the week: Convatec

Written by:
Helal Miah, investment research analyst at The Share Centre, picks global medical supplies and technology business Convatec as stock of the week.

Last week, Convatec reported its full year results which sent the shares up 7% on the day. The global medical supplies and technologies business reported revenue growth of 4.5%, including 2.3% of organic growth. It also turned from a loss last year of 15c per share to a profit of 8c a share on a reported basis. Even on an adjusted basis there was an impressive improvement, beating market expectations.

The underlying market which Convatec serves in is defensive in nature, but growth opportunities exist from ageing populations, the increased prevalence of chronic conditions and the fact that patients are living longer with these conditions. Of late, the group has experienced good growth with its Continence & Critical Care and Infusion Devices, while in Ostomy Care it has seen sales in the US, Latin America, Japan and China continue with good momentum. Investors should note that throughout the last year, it has expanded its portfolio with 16 new product launches.

The group’s full year results were particularly impressive given that in the market update, it reflected upon the many troubles it faced during 2017, including difficulties experienced in transferring manufacturing capabilities from the US to the Dominican Republic. We believe the difficulties the group face are temporary in nature and investors should appreciate that management remain optimistic and its guidance for 2018 is one of further improvement.

Overall, the group has shown some positive progress, it operates in a defensive market with significant growth opportunities. While the shares are a long way off from its highs, we believe this is a great opportunity to pick these shares up for the long-term. As a result, we recommend Convatec as a ‘buy’ for investors seeking a recovery potential and willing to accept a higher level of risk.

There are 0 Comment(s)

If you wish to comment without signing in, click your cursor in the top box and tick the 'Sign in as a guest' box at the bottom.

Big flu jab price hikes this winter: Where’s cheapest if you can’t get a free vaccine?

Pharmacies, supermarkets and health retailers are starting to offer flu jabs ahead of the winter season, but t...

Is now the time to fix your energy deal?

Fixed energy tariffs all but disappeared during the energy crisis. But now they are back with an increasing nu...

Everything you need to know about the pension triple lock

Retirees are braced to receive another bumper state pension pay rise next year due to the triple lock mechanis...

What will happen if rates change

How your finances will be impacted by a rise in interest rates.

Regular Savings Calculator

Small regular contributions can build up nicely over time.

Online Savings Calculator

Work out how your online savings can build over time.

The best student bank accounts in 2023: Cash offers, tastecards and 0% overdrafts

A number of banks are luring in new student customers with cold hard cash this year – while others are compe...

DIY investors: 10 common mistakes to avoid

For those without the help and experience of an adviser, here are 10 common DIY investor mistakes to avoid.

Mortgage down-valuations: Tips to avoid pulling out of a house sale

Down-valuations are on the rise. So, what does it mean for home buyers, and what can you do?

Money Tips of the Week